Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
accessed, Adda, Allergan, Altimmune, American, Arena, attached, Australia, auto, Bio, Bird, BMI, Callable, cohort, concomitant, constipation, crime, cyber, Daklinza, DC, died, elicit, encode, evidenced, explicit, fatigue, footnote, forward, furnish, gather, hand, HCC, HDL, headache, HEC, hepatic, HV, ILC, instrument, Inventiva, leave, ledipasir, ledipasvirm, line, Madrigal, MAVIRET, MAVYRET, MedImmune, mg, mild, mode, modification, Nathalie, nausea, NE, nominee, Notably, notification, Paramyxoviridae, Pfizer, PK, PN, proliferation, qui, readily, Republican, Rock, Room, scored, SH, sophistication, step, stopped, Subtopic, thereon, Transgene, transient, triple, Trump, UDCA, understood, unexercised, unwilling, urgency, volunteer, vosevi, voxilaprevir, wave, withholding, XR
Removed:
abandon, Afting, alisporivir, analogue, andin, anticipation, assay, bacteria, bacterial, boceprevir, characterized, circumstance, clear, commonin, competing, confounding, converted, countermeasure, cyclophilin, cyclosporine, decided, deducting, derivative, deteriorate, downturn, environment, essentially, execution, exemption, experiencing, experimental, forecasted, fundamental, genetic, globally, HTA, improve, Incivek, initiated, Insider, irrevocably, landscape, largely, macrolide, main, makeup, nucleoside, nucleotide, ofin, orqui, pegylated, permanently, prospectively, reassessed, redeemable, release, released, replicon, reversal, subsequently, subtype, telaprevir, terminal, underwriting, undesignated, usingin, validated, Vertex, whichever
Filing tables
Filing exhibits
Related press release
Associated ENTA transcripts
ENTA similar filings
Filing view
External links